Inventor

LI SZE-WAN

CA28 patents

⚠️ This page may combine multiple inventors who share the name “LI SZE-WAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LI SZE-WAN

UNIV HEALTH NETWORK

Pyrazolopyrimidine compounds

Pyrazolopyrimidine compounds

Kinase inhibitors and method of treating cancer

Kinase inhibitors and method of treating cancer

Kinase inhibitors and method of treating cancer

Kinase inhibitors and method of treating cancer with same

Pyrazolopyrimidine compounds

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

Solid forms of TTK inhibitor

Solid forms of TTK inhibitor

Kinase inhibitors and method of treating cancer with same

Pyrazolopyrimidine compounds

Pyrazolopyrimidine compounds

HPK1 inhibitors and methods of using same

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

Solid forms of TTK inhibitor

HPK1 inhibitors and methods of using same

Crystal form S4 of the PLK4 inhibitor (1R,2S)-(e)-2-(3-(4-((cis-2,6-dimethylmorpholino)methyl)styryl)-1 h-imidazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one fumarate

RIPK2 inhibitors and method of treating cancer with same

RIPK2 inhibitors and method of treating cancer with same

Indazole compounds as kinase inhibitors and method of treating cancer with same

SAMPSON PETER B

Kinase inhibitors and method of treating cancer

Kinase inhibitors and method of treating cancer

PAULS HEINZ W

Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancer

Kinase inhibitors and method of treating cancer with same

CUMMING GRAHAM

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

SAMPSON PETER BRENT

Kinase inhibitors and method of treating cancer with same